Teda Biotech announces 2023 performance, with shareholders' net loss of 20.16 million yuan, a year-on-year decrease of 26.56%
I'm PortAI, I can summarize articles.
According to the news from Zhitong Finance APP, Taeda Biotech announced its 2023 performance, with revenue of approximately 398 million yuan, a year-on-year decrease of 1.42%; shareholders' net loss was 20.16 million yuan, a year-on-year narrowing of 26.56%; loss per share was 1.06 cents
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments